Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)
Sarah E. Hoffe, Jessica M. Frakes, Todd A. Aguilera, Brian G. Czito, Manisha Palta, Melissa Brookes, Charles Schweizer, Lauren E. Colbert, Shalini Moningi, Manoop S. Bhutani, Shubham Pant, C.W. Tzeng, Rebecca S. Tidwell, Peter F. Thall, Ying Yuan, Elizabeth Charlotte Moser, Jon Holmlund, Joseph M. Herman, Cullen M. Taniguchi
Topics & Concepts
MedicineToxicityPlaceboPancreatic cancerSuperoxide dismutaseCancerPhases of clinical researchClinical trialIn vivoRadiation therapyOncologyInternal medicineUrologyPathologyOxidative stressBiotechnologyBiologyAlternative medicineGlioma Diagnosis and TreatmentCancer Treatment and PharmacologyAdvanced Radiotherapy Techniques